Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
Ophthalmic Evaluations in Clinical Studies of Fingolimod (FTY720) in Multiple Sclerosis.
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Amiloride HCI Tablets, USP 5 mg
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain. Reply].
Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.
Long term follow up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Safety Study of GNbAC1 in Multiple Sclerosis Patients
Cytotoxic NKG2C+ CD4 T Cells Target Oligodendrocytes in Multiple Sclerosis.
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
Fingolimod Therapy in Early Multiple Sclerosis: An Efficacy Analysis of the TRANSFORMS and FREEDOMS Studies by Time Since First Symptom.
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
Long-term follow-up of vanishing tumors in the brain: How should a lesion mimicking primary CNS lymphoma be managed?
The effect of Nintendo(R) Wii(R) on balance in people with multiple sclerosis: a pilot randomized control study.
Acorda Therapeutics announces positive AMPYRA® (dalfampridine) Phase 2 data in people with post-stroke deficits
Sanofi sees US FDA ruling for MS drug Lemtrada in Q4
Alemtuzumab as rescue therapy in a cohort of 16 aggressive multiple sclerosis patients previously treated by Mitoxantrone: an observational study.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Teva Announces Approval of Three-Times-A-Week COPAXONE® 40 mg/mL in Russia for the Treatment of Relapsing-Remitting Multiple Sclerosis
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
[Multiple sclerosis : actuality and therapeutic prospects].

Pages